CNS Pharmaceuticals, Inc. (CNSP)
| Market Cap | 7.75M-45.7% |
| Revenue (ttm) | 0 |
| Net Income | -16.70M-8.0% |
| EPS | -23.59+88.4% |
| Shares Out | 1.46M |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 843.612 |
| Open | 5.36 |
| Previous Close | 5.43 |
| Day's Range | 5.22 - 5.50 |
| 52-Week Range | 1.90 - 10.56 |
| Beta | 1.02 |
| Analysts | Buy |
| Price Target | 0.50(-90.57%) |
| Earnings Date | Nov 18, 2026 |
Insiders here have filed 1 Form 4 in the last 90 days, but all of them are share awards, grants or other non-market transactions. Those are compensation, not a decision to buy, so they are not scored.
About CNSP
CNS Pharmaceuticals, Inc., a clinical pharmaceutical company, engages in the development of therapies for neurology and oncology diseases in the United States. It develops TPI 287, an investigational chemotherapy agent, which is in Phase II clinical trial for the treatment of glioblastoma, metastatic breast cancer with brain metastases, non-small cell lung cancer, castration-resistant prostate cancer, and neuroblastoma; and Berubicin, an investigational anthracycline chemotherapy agent, which is in Phase II clinical trial for the treatment of glioblastoma and brain tumors. The company was incorporated in 2017 and is headquartered in Houston, Texas.
What Are Insiders Doing?
View the trades behind this meter — each links to its SEC Form 4 →
Open-market Form 4 purchases (code P) vs sales (code S) on file for this company. Grants, option exercises and tax withholdings are excluded. Informational only.
$CNSP stock is featured in our Insider Trades datasets.
→ All Stock ListsRecently reported changes in CNSP holdings by institutional investors
Latest 0 13F filings · Source: SEC EDGAR
View all institutional owners →Insider Trading
Quarterly net insider trading by CNSP's directors and management
Source: SEC EDGAR (Form 4)
Corporate Lobbying
CNSP Estimated quarterly lobbying spending
Source: U.S. Senate LDA
U.S. Patents
New CNSP patent grants
Source: USPTO Open Data Portal
Government Contracts
Estimated quarterly amount awarded to CNSP from public contracts
Source: USAspending.gov
Top ETF Holders
ETFs with the largest estimated holdings in CNSP
| ETF | Est. Holding Size |
|---|---|
| VXFVanguard Extended Market ETF | $41.89K |
Estimated from each fund’s disclosed top holdings × AUM
CNSP Insider Score
Our composite score: insider buying, sector, volume, tone & dilution
Bull Case vs Bear Case
AI-generated from CNSP’s recent data — informational, not investment advice